Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
Making medicines has never been easy. But in today’s global health care environment, the challenges are unprecedented. Familiar ways of working aren’t working anymore, so Lilly is transforming to meet the challenges head on — from how we make medicines to how we talk about them. Throughout our organization, we’re asking tough questions and discovering better answers.
AgNovos Healthcare is a privately held medical device company focused on bone health, a crucial quality-of-life issue facing the aging population. Founded by renowned orthopedic surgeon Dr. James Howe, AgNovos is headquartered in Rockville, MD. Through scientific rigor and the compassion born of Dr. Howe’s decades of working with patients, AgNovos Healthcare aims to reduce the devastating personal and societal costs of diseases like osteoporosis. The company is developing innovative treatments that have the potential to alter the landscape of bone health. By bringing new technology to market, the company strives to help patients maintain their mobility and independence.
Radius is a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases.
Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis patient population. Their lead product candidate, the investigational drug abaloparatide, is a bone anabolic for potential use in the treatment of postmenopausal women with osteoporosis. They are developing two formulations of abaloparatide: abaloparatide-SC, an injectable subcutaneous formulation, and abaloparatide-TD, a line extension of abaloparatide-SC in the form of a convenient, short-wear-time transdermal patch.
The Global Healthy Living Foundation is a 501(c)(3) non-profit advocacy organization, based in New York, with the mission to improve the quality of life for people with chronic illness. The GHLF accomplishes its mission by advocating for improved access to care and by educating the community about the importance of diagnosis, early and innovative medical intervention, long-term lifestyle improvement, and therapeutic compliance.
As a leading global healthcare and diagnostics company, Hologic strives to make advances toward greater certainty for their customers by providing them with cutting-edge technology that makes a real difference.